Inspire Veterinary Partners, Inc. - Class A Common Stock (IVP)

VIRGINIA BEACH, VA / ACCESS Newswire / April 10, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced its upcoming investor event attendance.

VIRGINIA BEACH, VA / ACCESS Newswire / March 31, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported financial results for the full year ended December 31, 2024.

NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / On Mar. 26, 2025, Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., announced it has closed a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million (the "Offering"). The Series A warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants (the "Stockholder Approval Date") and will expire five years from the Stockholder Approval Date. The Series B warrants will be exercisable beginning on the Stockholder Approval Date and will expire 18 months from the Stockholder Approval Date. The purchase price for one share of common stock (or pre-funded warrants in lieu thereof) and accompanying two warrants is $1.83. Approximately $2.0 million will be funded in full upon the closing of the Offering, and up to an additional $4.0 million may be funded upon full cash exercise of the warrants. No assurance can be given that any of the warrants will be exercised.

VIRGINIA BEACH, VA / ACCESS Newswire / March 26, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced it has closed a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million (the "Offering").The Series A warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants (the "Stockholder Approval Date") and will expire five years from the Stockholder Approval Date. The Series B warrants will be exercisable beginning on the Stockholder Approval Date and will expire 18 months from the Stockholder Approval Date. The purchase price for one share of common stock (or pre-funded warrants in lieu thereof) and accompanying two warrants is $1.83. Approximately $2.0 million will be funded in full upon the closing of the Offering, and up to an additional $4.0 million may be funded upon full cash exercise of the warrants. No assurance can be given that any of the warrants will be exercised.

Inspire plans to replicate the design of its Texas based Family Pet Care state-of-the-art facility in new or future upgrades across the IVP platform

VIRGINIA BEACH, VA / ACCESS Newswire / March 25, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.,today announced it has entered into a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or a pre-funded warrant in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million before deducting fees and other estimated offering expenses (the "Offering").The Series A warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares underlying the warrants (the "Stockholder Approval Date") and will expire five years from the Stockholder Approval Date. The Series B warrants will be exercisable beginning on the Stockholder Approval Date and will expire 18 months from the Stockholder Approval Date. The purchase price for one share of common stock (or pre-funded warrants in lieu thereof) and accompanying two warrants is $1.83. Approximately $2.0 million will be funded in full upon the closing of the Offering, and up to an additional $4.0 million may be funded upon full cash exercise of the warrants. No assurance can be given that any of the warrants will be exercised. The offering is expected to close on or about March 26, 2025, subject to the satisfaction of customary closing conditions.

Proposed acquisition could potentially add approximately $1.8 million (unaudited) revenue, increase Inspire's current locations in Florida to 5, and bring the total number of animal hospitals in its network to 14.

VIRGINIA BEACH, VA / ACCESS Newswire / March 3, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.,today announced it has engaged STNL Advisors, a full-service net lease advisory firm, to review the Company's real estate portfolio and provide strategic guidance on opportunities to expand, update and add new facilities.

VIRGINIA BEACH, VA / ACCESS Newswire / February 12, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.,today issued a letter to stockholders from Kimball Carr, the Chief Executive Officer of Inspire.

Ciulla has over a decade of leadership experience in operations, acquisition integration and business development within the veterinary sector

Strategy includes multiple paths for long-term growth in the economically resilient pet health and wellness marketplace

(This release updates the release that posted on May 6, 2024 to correct the total number of shares of Common Stock and the date the Company's board approved the reverse stock split)

VIRGINIA BEACH, VA / ACCESS Newswire / January 22, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it will effect a 1-for-25 reverse stock split ("Reverse Stock Split") of its authorized and issued and outstanding shares of Class A common stock, par value $0.0001 per share ("Common Stock"). The Reverse Stock Split will become effective at 12:01am, Eastern Time, on January 27, 2025. At such time, each 25 shares of issued and outstanding Common Stock will automatically be reclassified into one new share of Common Stock. The total number of shares of Common Stock authorized for issuance will then be reduced by a corresponding proportion from 36,998,148 shares to 1,479,926 shares. Proportional adjustments will also be made to outstanding equity awards, warrants and convertible notes, and to the number of shares issued and issuable under the Company's stock incentive plans and certain existing agreements. No fractional shares will be issued in connection with the Reverse Stock Split. All fractional shares will be rounded up. The Reverse Stock Split will affect all common stockholders uniformly and will not alter any stockholder's percentage interest in the Company's equity.

VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported its financial results for the third quarter and nine months ended September 30, 2024.

VIRGINIA BEACH, VA / ACCESSWIRE / October 22, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has entered into a securities purchase agreement with institutional investors, providing for the purchase and sale of 10,000,000 million shares of Class A common stock in a registered direct offering, at a price per share of $0.25. The offering is expected to close on or about October 23, 2024, subject to the satisfaction of customary closing conditions.

VIRGINIA BEACH, VA / ACCESSWIRE / August 27, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has entered into a non-binding letter of intent (the "LOI") with Vetsie.ai, an Artificial Intelligence ("AI") software platform designed to empower veterinary professionals with quick, accurate access to critical information on patient conditions, treatments, and medications, to engage in diligence and initial negotiations regarding the terms of a potential transaction whereby Inspire may Acquire Vetsie.ai in an all- stock transaction. This potential equity-only acquisition, if consummated, would be completed without the need for any operating capital infusion from Inspire into the acquired business for the first fiscal year.

VIRGINIA BEACH, VA / ACCESSWIRE / August 20, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced its plans to accelerate its growth through acquisitions of single and multi-unit providers, broadening its service offerings, and enhancing business operations and consumer engagement by implementing Artificial Intelligence (AI) tools.

VIRGINIA BEACH, VA / ACCESSWIRE / August 16, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that its board of directors has nominated Phillip Balatsos to stand for election as an independent director at its annual meeting of stockholders on October 9, 2024.

VIRGINIA BEACH, VA / ACCESSWIRE / August 14, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported its financial results for the second quarter and six months ended June 30, 2024.

VIRGINIA BEACH, VA / ACCESSWIRE / July 31, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that Kimball Carr, President & Chief Executive Officer of Inspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 14th at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.meetmax.com/sched/event_108949/conference_presentations.html

VIRGINIA BEACH, VA / ACCESSWIRE / July 24, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today issued a corporate update in a Letter to Shareholders from CEO & President, Kimball Carr.

VIRGINIA BEACH, VA / ACCESSWIRE / July 10, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced the closing of its previously announced public offering of 6,000,000 units, each unit consisting of either one share of the Company's Class A common stock or one pre-funded warrant to purchase one share of the Company's Class A common stock and one warrant to purchase one share of the Company's Class A common stock at a public offering price of $1.00 per unit.The pre-funded warrants are issuable to purchasers in lieu of shares of Class A common stock that would otherwise result in such purchaser's beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of the Company's outstanding Class A common stock, if any such purchaser so chooses. Each pre-funded warrant is exercisable at any time to purchase one common share at an exercise price of $0.0001 per share. Gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, were approximately $6.0 million. The Company intends to use the proceeds of the offering for working capital, general corporate purposes, payments to a third-party marketing agency for services related to marketing and advertising, strategic investments, and any additional future acquisition (if any).

VIRGINIA BEACH, VA / ACCESSWIRE / July 8, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., announces the pricing of its public offering of 6,000,000 units, each unit consisting of either one share of the Company's Class A common stock or one pre-funded warrant to purchase one share of the Company's Class A common stock and one warrant to purchase one share of the Company's Class A common stock at a public offering price of $1.00 per unit.The pre-funded warrants are issuable to purchasers in lieu of shares of Class A common stock that would otherwise result in such purchaser's beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of the Company's outstanding Class A common stock, if any such purchaser so chooses. Each pre-funded warrant is exercisable at any time to purchase one common share at an exercise price of $0.0001 per share. Gross proceeds from the Offering, before deducting the placement agent's fees and other offering expenses, were approximately $6.0 million. The Company intends to use the proceeds of the offering for working capital, general corporate purposes, payments to a third-party marketing agency for services related to marketing and advertising, strategic investments, and any additional future acquisition (if any).

VIRGINIA BEACH, VA / ACCESSWIRE / May 15, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported its financial results for the first quarter ended March 31, 2024.

VIRGINIA BEACH, VA / ACCESSWIRE / May 6, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it will effect a 1-for-100 reverse stock split ("Reverse Stock Split") of its authorized and issued and outstanding shares of Class A common stock, par value $0.0001 per share ("Common Stock"). The Reverse Stock Split will become effective at 12:01am, Eastern Time, on May 8, 2024. At such time, each 100 shares of issued and outstanding Common Stock will automatically be reclassified into one new share of Common Stock. The total number of shares of Common Stock authorized for issuance will then be reduced by a corresponding proportion from 100,00,000 shares to 1,000,000 shares. Proportional adjustments also will be made to outstanding equity awards, warrants and convertible notes, and to the number of shares issued and issuable under the Company's stock incentive plans and certain existing agreements. No fractional shares will be issued in connection with the Reverse Stock Split. All fractional shares will be rounded up. The Reverse Stock Split will affect all common stockholders uniformly and will not alter any stockholder's percentage interest in the Company's equity.